ATX 4.92% 6.4¢ amplia therapeutics limited

Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer, page-21

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    wouldn’t over - interpret the results, you’re comparing 14 patients here vs a study 30x the size, it only takes one to go the other way and with such a small sample the % response won’t look so good. Best we can say is it’s met its objective of finding a dose to take into the next phase and initial response rates are ok.
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.4¢
Change
0.003(4.92%)
Mkt cap ! $17.38M
Open High Low Value Volume
6.1¢ 6.6¢ 6.1¢ $28.65K 462.7K

Buyers (Bids)

No. Vol. Price($)
2 50642 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.6¢ 131151 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.